Contact this trialFirst, we need to learn more about you.
Chemotherapy
Azacitidine +3 More for Acute Leukemia
Recruiting1 awardPhase 1
Memphis, Tennessee
This trial is studying the safety and effectiveness of adding a new drug called revumenib to standard chemotherapy drugs for treating patients with acute myeloid leukemia (AML) or acute leukemia of ambiguous lineage (
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.